Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Assets (2021 - 2025)

Xeris Biopharma Holdings (XERS) has disclosed Return on Assets for 5 consecutive years, with 0.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 17.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Dec 2025, up 17.0%, and an annual FY2025 reading of 0.0%, up 17.0% over the prior year.
  • Return on Assets was 0.0% for Q4 2025 at Xeris Biopharma Holdings, up from 0.04% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.56% in Q4 2021.
  • Average Return on Assets over 5 years is 0.23%, with a median of 0.19% recorded in 2024.
  • The sharpest move saw Return on Assets rose 27bps in 2022, then dropped -1bps in 2024.
  • Year by year, Return on Assets stood at 0.56% in 2021, then soared by 48bps to 0.29% in 2022, then soared by 35bps to 0.19% in 2023, then increased by 11bps to 0.17% in 2024, then soared by 101bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for XERS at 0.0% in Q4 2025, 0.04% in Q3 2025, and 0.1% in Q2 2025.